{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:02:09Z","timestamp":1772539329937,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"DOI":"10.1007\/s10006-022-01061-2","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T15:26:27Z","timestamp":1648826787000},"page":"251-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Surgical treatment of 61 consecutive patients with maxillary stage 3 medication\u2013related osteonecrosis of the jaws using a pedicled buccal fat pad"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-2895","authenticated-orcid":false,"given":"Sanne Werner Moeller","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ditte Gertz","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Schioedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2445-6451","authenticated-orcid":false,"given":"Thomas","family":"Kofod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"issue":"9","key":"1061_CR1","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115\u20131117. https:\/\/doi.org\/10.1016\/s0278-2391(03)00720-1","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"1061_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"SL Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62(5):527\u2013534. https:\/\/doi.org\/10.1016\/j.joms.2004.02.004","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"1061_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/jop.2006.2.1.7","volume":"2","author":"S Ruggiero","year":"2006","unstructured":"Ruggiero S, Gralow J, Marx RE, Hoff AO, Schubert MM, Huryn JM, Toth B, Damato K, Valero V (2006) Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2(1):7\u201314. https:\/\/doi.org\/10.1200\/jop.2006.2.1.7","journal-title":"J Oncol Pract"},{"issue":"3","key":"1061_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1747-4477.2009.00213.x","volume":"35","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw \u2014 2009 update. Aust Endod J 35(3):119\u2013130. https:\/\/doi.org\/10.1111\/j.1747-4477.2009.00213.x","journal-title":"Aust Endod J"},{"issue":"10","key":"1061_CR5","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72(10):1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"1061_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.oooo.2013.10.010","volume":"117","author":"M Schiodt","year":"2014","unstructured":"Schiodt M, Reibel J, Oturai P, Kofod T (2014) Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system. Oral Surg Oral Med Oral Pathol Oral Radiol 117(2):204\u2013213. https:\/\/doi.org\/10.1016\/j.oooo.2013.10.010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1061_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","volume":"69","author":"S Otto","year":"2018","unstructured":"Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schi\u00f8dt M (2018) Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev 69:177\u2013187. https:\/\/doi.org\/10.1016\/j.ctrv.2018.06.007","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"1061_CR8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carriere P, Dansey R (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23(5):1341\u20131347. https:\/\/doi.org\/10.1093\/annonc\/mdr435","journal-title":"Ann Oncol"},{"issue":"1","key":"1061_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00006534-199001000-00006","volume":"85","author":"JM Stuzin","year":"1990","unstructured":"Stuzin JM, Wagstrom L, Kawamoto HK, Baker TJ, Wolfe SA (1990) The anatomy and clinical applications of the buccal fat pad. Plast Reconstr Surg 85(1):29\u201337. https:\/\/doi.org\/10.1097\/00006534-199001000-00006","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"1061_CR10","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ijom.2012.04.001","volume":"41","author":"S Nabil","year":"2012","unstructured":"Nabil S, Ramli R (2012) The use of buccal fat pad flap in the treatment of osteoradionecrosis. Int J Oral Maxillofac Surg 41(11):1422\u20131426. https:\/\/doi.org\/10.1016\/j.ijom.2012.04.001","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"5","key":"1061_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ijom.2012.07.009","volume":"42","author":"Y Toshihiro","year":"2013","unstructured":"Toshihiro Y, Nariai Y, Takamura Y, Yoshimura H, Tobita T, Yoshino A, Tatsumi H, Tsunematsu K, Ohba S, Kondo S, Yanai C, Ishibashi H, Sekine J (2013) Applicability of buccal fat pad grafting for oral reconstruction. Int J Oral Maxillofac Surg 42(5):604\u2013610. https:\/\/doi.org\/10.1016\/j.ijom.2012.07.009","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"6","key":"1061_CR12","first-page":"283","volume":"64","author":"A Castellani","year":"2015","unstructured":"Castellani A, Bocchialini G, Negrini S, Zanetti U, Rossi A (2015) The pedicled buccal fat pad in oral reconstruction. Minerva Stomatol 64(6):283\u2013293","journal-title":"Minerva Stomatol"},{"issue":"2","key":"1061_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1834-7819.2012.01675.x","volume":"57","author":"I Hewson","year":"2012","unstructured":"Hewson I, Syme D, Bruscino-Raiola F (2012) Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw. Aust Dent J 57(2):227\u2013230. https:\/\/doi.org\/10.1111\/j.1834-7819.2012.01675.x","journal-title":"Aust Dent J"},{"issue":"5","key":"1061_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jcms.2008.12.004","volume":"37","author":"T Mucke","year":"2009","unstructured":"Mucke T, Haarmann S, Wolff KD, Holzle F (2009) Bisphosphonate related osteonecrosis of the jaws treated by surgical resection and immediate osseous microvascular reconstruction. J Craniomaxillofac Surg 37(5):291\u2013297. https:\/\/doi.org\/10.1016\/j.jcms.2008.12.004","journal-title":"J Craniomaxillofac Surg"},{"issue":"3","key":"1061_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1590\/0103-6440201301918","volume":"26","author":"LFM Duarte","year":"2015","unstructured":"Duarte LFM, Alonso K, Basso EC, Dib LL (2015) Surgical treatment of bisphosphonate-related osteonecrosis of the jaws with the use of buccal fat pad: case report. Braz Dent J 26(3):317\u2013320. https:\/\/doi.org\/10.1590\/0103-6440201301918","journal-title":"Braz Dent J"},{"issue":"3","key":"1061_CR16","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1097\/scs.0000000000002579","volume":"27","author":"SA Denes","year":"2016","unstructured":"Denes SA, Tieghi R, Elia G (2016) The buccal fat pad for closure of oroantral communication. J Craniofac Surg 27(3):e327-330. https:\/\/doi.org\/10.1097\/scs.0000000000002579","journal-title":"J Craniofac Surg"},{"key":"1061_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0000000000005472","author":"O \u015eahin","year":"2019","unstructured":"\u015eahin O, Odaba\u015f\u0131 O, Ekmekcio\u011flu C (2019) Ultrasonic piezoelectric bone surgery combined with L-PRF and pedicled buccal fat pad flap in denosumab-related osteonecrosis of the jaw. J Craniofac Surg. https:\/\/doi.org\/10.1097\/SCS.0000000000005472","journal-title":"J Craniofac Surg"},{"key":"1061_CR18","doi-asserted-by":"publisher","unstructured":"Gallego L, Junquera L, Pelaz A, Hernando J, Megias J (2012) The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxilla. Medicina Oral Patolog\u00eda Oral y Cirugia Bucal: e236-e241. https:\/\/doi.org\/10.4317\/medoral.17422","DOI":"10.4317\/medoral.17422"},{"issue":"11","key":"1061_CR19","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.joms.2015.06.165","volume":"73","author":"M Berrone","year":"2015","unstructured":"Berrone M, Florindi FU, Carbone V, Aldiano C, Pentenero M (2015) Stage 3 medication-related osteonecrosis of the posterior maxilla: surgical treatment using a pedicled buccal fat pad flap: case reports. J Oral Maxillofac Surg 73(11):2082\u20132086. https:\/\/doi.org\/10.1016\/j.joms.2015.06.165","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"1061_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.joms.2014.09.023","volume":"73","author":"H Rotaru","year":"2015","unstructured":"Rotaru H, Kim MK, Kim SG, Park YW (2015) Pedicled buccal fat pad flap as a reliable surgical strategy for the treatment of medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg 73(3):437\u2013442. https:\/\/doi.org\/10.1016\/j.joms.2014.09.023","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"1061_CR21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jcms.2018.03.007","volume":"46","author":"K Hakobyan","year":"2018","unstructured":"Hakobyan K, Poghosyan Y, Kasyan A (2018) The use of buccal fat pad in surgical treatment of \u2018Krokodil\u2019 drug-related osteonecrosis of maxilla. J Craniomaxillofac Surg 46(5):831\u2013836","journal-title":"J Craniomaxillofac Surg"},{"key":"1061_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10006-021-00973-9","volume":"1","author":"A Jose","year":"2021","unstructured":"Jose A, Rawat A, Nagori SA, Arya S, Shukla D (2021) Outcomes of sequestrectomy and buccal fat pad reconstruction in the management of medication-related osteonecrosis of the jaws. Oral Maxillofac Surg 1:3. https:\/\/doi.org\/10.1007\/s10006-021-00973-9","journal-title":"Oral Maxillofac Surg"},{"key":"1061_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/odi.12992","author":"S Aljohani","year":"2018","unstructured":"Aljohani S, Troeltzsch M, Hafner S, Kaeppler G, Mast G, Otto S (2018) Surgical treatment of medication-related osteonecrosis of the upper jaw: case series. Oral Dis. https:\/\/doi.org\/10.1111\/odi.12992","journal-title":"Oral Dis"},{"issue":"3","key":"1061_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.oooo.2016.03.015","volume":"122","author":"JC Melville","year":"2016","unstructured":"Melville JC, Tursun R, Shum JW, Young S, Hanna IA, Marx RE (2016) A technique for the treatment of oral-antral fistulas resulting from medication-related osteonecrosis of the maxilla: the combined buccal fat pad flap and radical sinusotomy. Oral Surg Oral Med Oral Pathol Oral Radiol 122(3):287\u2013291. https:\/\/doi.org\/10.1016\/j.oooo.2016.03.015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"5","key":"1061_CR25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jcms.2018.03.005","volume":"46","author":"O Ristow","year":"2018","unstructured":"Ristow O, R\u00fcckschlo\u00df T, Bodem J, Berger M, Bodem E, Kargus S, Engel M, Hoffmann J, Freudlsperger C (2018) Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw \u2014 a single center cohort study. J Craniomaxillofac Surg 46(5):815\u2013824. https:\/\/doi.org\/10.1016\/j.jcms.2018.03.005","journal-title":"J Craniomaxillofac Surg"},{"key":"1061_CR26","doi-asserted-by":"publisher","unstructured":"Laimer J, H\u00f6ller A, Pichler U, Engel R, Neururer SB, Egger A, Griesmacher A, Bruckmoser E (2021) Nutritional status in patients with medication-related osteonecrosis of the jaw (MRONJ). Nutrients 13 (5). doi:https:\/\/doi.org\/10.3390\/nu13051585","DOI":"10.3390\/nu13051585"},{"issue":"8360","key":"1061_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/s0140-6736(83)91226-6","volume":"2","author":"AM Parfitt","year":"1983","unstructured":"Parfitt AM (1983) Dietary risk factors for age-related bone loss and fractures. Lancet 2(8360):1181\u20131185. https:\/\/doi.org\/10.1016\/s0140-6736(83)91226-6","journal-title":"Lancet"},{"issue":"6","key":"1061_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649\u2013655","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"1061_CR29","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.jcms.2019.11.002","volume":"47","author":"K Hakobyan","year":"2019","unstructured":"Hakobyan K, Poghosyan Y (2019) \u201cKrokodil\u201d drug \u2014 related osteonecrosis of midface: a case series. J Craniomaxillofac Surg 47(12):1918\u20131921. https:\/\/doi.org\/10.1016\/j.jcms.2019.11.002","journal-title":"J Craniomaxillofac Surg"},{"issue":"4","key":"1061_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1259\/dmfr\/27458726","volume":"35","author":"S Chiandussi","year":"2006","unstructured":"Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R (2006) Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 35(4):236\u2013243. https:\/\/doi.org\/10.1259\/dmfr\/27458726","journal-title":"Dentomaxillofac Radiol"},{"issue":"1","key":"1061_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2500\/ajra.2017.31.4395","volume":"31","author":"O Wasserzug","year":"2017","unstructured":"Wasserzug O, Kaffe I, Lazarovici TS, Weissman T, Yahalom R, Fliss DM, Yarom N (2017) Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: radiologic aspects. Am J Rhinol Allergy 31(1):36\u201339. https:\/\/doi.org\/10.2500\/ajra.2017.31.4395","journal-title":"Am J Rhinol Allergy"},{"issue":"7","key":"1061_CR32","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/odi.13160","volume":"25","author":"M Schiodt","year":"2019","unstructured":"Schiodt M, Otto S, Fedele S, Bedogni A, Nicolatou-Galitis O, Guggenberger R, Herlofson BB, Ristow O, Kofod T (2019) Workshop of European task force on medication-related osteonecrosis of the jaw\u2014current challenges. Oral Dis 25(7):1815\u20131821. https:\/\/doi.org\/10.1111\/odi.13160","journal-title":"Oral Dis"},{"issue":"5","key":"1061_CR33","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ijom.2015.01.014","volume":"44","author":"M Nisi","year":"2015","unstructured":"Nisi M, La Ferla F, Karapetsa D, Gennai S, Miccoli M, Baggiani A, Graziani F, Gabriele M (2015) Risk factors influencing BRONJ staging in patients receiving intravenous bisphosphonates: a multivariate analysis. Int J Oral Maxillofac Surg 44(5):586\u2013591. https:\/\/doi.org\/10.1016\/j.ijom.2015.01.014","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"7","key":"1061_CR34","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.joms.2016.12.014","volume":"75","author":"HY Kim","year":"2017","unstructured":"Kim HY, Lee SJ, Kim SM, Myoung H, Hwang SJ, Choi JY, Lee JH, Choung PH, Kim MJ, Seo BM (2017) Extensive surgical procedures result in better treatment outcomes for bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis. J Oral Maxillofac Surg 75(7):1404\u20131413. https:\/\/doi.org\/10.1016\/j.joms.2016.12.014","journal-title":"J Oral Maxillofac Surg"},{"issue":"7","key":"1061_CR35","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jcms.2011.10.012","volume":"40","author":"G Mast","year":"2012","unstructured":"Mast G, Otto S, M\u00fccke T, Schreyer C, Bissinger O, Kolk A, Wolff KD, Ehrenfeld M, St\u00fcrzenbaum SR, Pautke C (2012) Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw. J Craniomaxillofac Surg 40(7):568\u2013571. https:\/\/doi.org\/10.1016\/j.jcms.2011.10.012","journal-title":"J Craniomaxillofac Surg"},{"key":"1061_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2020.03.010","author":"J Murphy","year":"2020","unstructured":"Murphy J, Mannion CJ (2020) Medication-related osteonecrosis of the jaws and quality of life: review and structured analysis. Br J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.bjoms.2020.03.010","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"2","key":"1061_CR37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.oooo.2020.03.051","volume":"130","author":"T Sato","year":"2020","unstructured":"Sato T, Kusumoto J, Takeda D, Kishimoto M, Kashin M, Furudoi S, Akashi M (2020) Which symptoms negatively affect the oral health-related quality of life in patients with osteonecrosis of the jaw? Oral Surg Oral Med Oral Pathol Oral Radiol 130(2):175\u2013180. https:\/\/doi.org\/10.1016\/j.oooo.2020.03.051","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"4","key":"1061_CR38","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.joms.2007.11.025","volume":"66","author":"P Vescovi","year":"2008","unstructured":"Vescovi P, Manfredi M, Merigo E, Meleti M (2008) Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 66(4):831\u2013832. https:\/\/doi.org\/10.1016\/j.joms.2007.11.025","journal-title":"J Oral Maxillofac Surg"},{"key":"1061_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2016.05.018","author":"S Otto","year":"2016","unstructured":"Otto S, Ristow O, Pache C, Troeltzsch M, Fliefel R, Ehrenfeld M, Pautke C (2016) Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: a prospective cohort study. J Craniomaxillofac Surg. https:\/\/doi.org\/10.1016\/j.jcms.2016.05.018","journal-title":"J Craniomaxillofac Surg"},{"issue":"2","key":"1061_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijom.2016.10.008","volume":"46","author":"O Ristow","year":"2017","unstructured":"Ristow O, Otto S, Geiss C, Kehl V, Berger M, Troeltzsch M, Koerdt S, Hohlweg-Majert B, Freudlsperger C, Pautke C (2017) Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study. Int J Oral Maxillofac Surg 46(2):157\u2013166. https:\/\/doi.org\/10.1016\/j.ijom.2016.10.008","journal-title":"Int J Oral Maxillofac Surg"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-022-01061-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10006-022-01061-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-022-01061-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T08:08:03Z","timestamp":1685606883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10006-022-01061-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1007\/s10006-022-01061-2","relation":{},"ISSN":["1865-1569"],"issn-type":[{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"assertion":[{"value":"15 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethic committee H-6\u20132013-010 November 20, 2013.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients signed an informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Morten Schiodt has been a consultant for Amgen. Other authors have no conflicts of interest to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}